Xu Cong Claire
EVP, Clinical Development at NBP
- Sold, on record
- $20k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Aug 31, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NBPNovaBridge BiosciencesEVP, Clinical Development
Sales by reason
0
Routine
0
Plan not stated
3
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NBPNo planJun 1, 2026 2026
Sold 3,494 shares at $3.94 ($14k)
Xu Cong Claire, SVP, Clinical Development
No 10b5-1 planSold 1.2% of holdings ($1.2M position)290,154 shares leftFirst sale on recordFiling
- 2 Form 4 sale NBPNo planJul 6, 2026 +35 days
Sold 4,485 shares at $0.89 ($4k)
Xu Cong Claire, SVP, Clinical Development
No 10b5-1 planSold 1.5% of holdings ($269k position)298,101 shares leftFiling
- 3 Form 4 sale NBPNo planAug 31, 2026 +56 days
Sold 3,282 shares at $0.79 ($3k)
Xu Cong Claire, EVP, Clinical Development
No 10b5-1 planSold 1.1% of holdings ($243k position)304,201 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Sep 1, 2026 | NBP | EVP, Clinical Development | Form 4 sale | 3,282 | $3k | 1.1% | No plan | SEC |
| Jul 6, 2026 | Jul 7, 2026 | NBP | SVP, Clinical Development | Form 4 sale | 4,485 | $4k | 1.5% | No plan | SEC |
| Jun 1, 2026 | Jun 2, 2026 | NBP | SVP, Clinical Development | Form 4 sale | 3,494 | $14k | 1.2% | No plan | SEC |